Refractory or Recurrent Metastatic Breast Cancer
Links shared publicly online about this topic.
- 3total visits
Refractory or Recurrent Metastatic Breast Cancer
View full resource at mbc.cancerlearning.com
Tags: Cancer, Breast Cancer, Metastatic Breast Cancer, Women's Health
Most Recently Shared on September 13, 2011 at 3:15 am By:
Free web-based interactive CME activity: Refractory or Recurrent Metastatic Breast Cancer #breastcancer http://ow.ly/6rR40
Oncology News - Implications of Different CA 15-3 Levels according to Breast Cancer Subtype at Initial Diagnosis of Recurrent or Metastatic Breast Cancer |3982306
mdlinx.com — “Oncology Medical Article: Implications of Different CA 15-3 Levels according to Breast Cancer Subtype at Initial Diagnosis of Recurrent or Metastatic Breast Cancer” View full resource at mdlinx.com
Most Recently Shared on March 19, 2012 at 6:03 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Implications of Different CA 15-3 Levels according to Breast Cancer Subtype at Initial Diagnosis of Re... http://t.co/XrzteuLV #oncology
Implications of Different CA 15-3 Levels according to Breast Cancer Subtype at Initial Diagnosis of Recurrent or Metastatic Breast Cancer
content.karger.com — “Implications of Different CA 15-3 Levels according to Breast Cancer Subtype at Initial Diagnosis of Recurrent or Metastatic Breast Cancer” View full resource at content.karger.com
Most Recently Shared on March 15, 2012 at 10:43 pm By:
Implications of Different CA 15-3 Levels according to Breast Cancer Subtype at Initial Diagnosis of Recurrent or... http://t.co/z049ivMC
Oncology Medical Article | Eribulin Mesylate for the Treatment of Patients with Refractory Metastatic Breast Cancer
mdlinx.com — “Oncology Medical Article: Eribulin Mesylate for the Treatment of Patients with Refractory Metastatic Breast Cancer” View full resource at mdlinx.com
Most Recently Shared on March 13, 2012 at 5:46 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Eribulin Mesylate for the Treatment of Patients with Refractory Metastatic Breast Cancer: Clinical Can... http://t.co/dZBd9SvA #oncology
Recurrent and Metastatic Breast Cancer
breastcancer.org — “breast cancer recurrence and metastasis” View full resource at breastcancer.org
Most Recently Shared on October 13, 2011 at 9:19 pm By:
Alicia C. Staley Patient Expert and Health Social Media
RT @BCAction: Learn about Metastatic #BreastCancer today! http://t.co/EYovQVK4 Time to talk about this devastating disease. #BCSM #MBC
Oncology Article | Colorectal Neoplasms
mdlinx.com — “The fate of camptothecin glycoconjugate: Report of a clinical hold during a phase II study of BAY 56-3722 (formerly BAY 38-3441), in patients with recurrent or metastatic colorectal cancer resistant/refractory to irinotecan” View full resource at mdlinx.com
Most Recently Shared on May 17, 2011 at 8:28 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
The fate of camptothecin glycoconjugate: Report of a clinical hold during a phase II study of BAY 56-3... http://bit.ly/lqmxoA #oncology
Halaven (eribulin): New breast cancer treatment | MIMS online
mims.co.uk — “Halaven has been launched for the treatment of advanced or metastatic breast cancer. Eribulin for the treatment of breast cancer refractory to other chemotherapy regimens.” View full resource at mims.co.uk
Most Recently Shared on May 5, 2011 at 10:46 am By:
New breast cancer treatment eribulin (Halaven) listed in MIMS: http://bit.ly/iZizfr
Sun Pharma Announces US FDA Approval for Docefrez (docetaxel) for Injection
drugs.com — “Docefrez (docetaxel) is used to treat metastatic breast cancer, locally advanced or metastatic non-small cell lung cancer and hormone refractory metastatic prostate cancer. Includes Docefrez side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on May 5, 2011 at 12:12 am By:
Drugs and Devices OW OW Health
Sun Pharma Announces US FDA Approval for Docefrez (docetaxel) for Injection: Mumbai, May 4, 2011: Sun Phar... http://bit.ly/jq8d86 #drug
Sun Pharma Announces US FDA Approval for Docefrez (docetaxel) for Injection
drugs.com — “Docefrez (docetaxel) is used to treat metastatic breast cancer, locally advanced or metastatic non-small cell lung cancer and hormone refractory metastatic prostate cancer. Includes Docefrez side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on May 4, 2011 at 11:19 pm By:
Sun Pharma Announces US FDA Approval for Docefrez (docetaxel) for Injection - http://bit.ly/kreMHf
Oncology Article | Breast Neoplasms Quality of Life
mdlinx.com — “Impact of lapatinib plus trastuzumab versus single-agent lapatinib on quality of life of patients with trastuzumab-refractory HER2+ metastatic breast cancer” View full resource at mdlinx.com
Most Recently Shared on March 22, 2011 at 6:27 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Impact of lapatinib plus trastuzumab versus single-agent lapatinib on quality of life of patients with... http://bit.ly/eNh7Xk #oncology
Oncology Article | Breast Neoplasms Paclitaxel
mdlinx.com — “Motesanib, or open-label bevacizumab, in combination with paclitaxel, as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: A phase 2, randomised, double-blind, placebo-controlled study” View full resource at mdlinx.com
Most Recently Shared on March 22, 2011 at 5:53 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Motesanib, or open-label bevacizumab, in combination with paclitaxel, as first-line treatment for HER2... http://bit.ly/gUe2Gb #oncology
Eribulin offers new survival hope in recurrent or metastatic breast cancer - ONA
oncologynurseadvisor.com — “The drug eribulin significantly improved survival among women with recurrent or metastatic breast cancer, establishing a potential new standard treatment for such patients.” View full resource at oncologynurseadvisor.com
Most Recently Shared on March 14, 2011 at 11:31 am By:
OncologyNurseAdvisor Medical Education, Medical Publisher, Oncology, and Nursing
Eribulin offers new survival hope in recurrent or metastatic breast cancer http://goo.gl/fb/OWAhy
Detecting breast cancer recurrence
physorg.com — “Connie Krabbe understands the fear and foreboding breast cancer survivors feel when visiting their physicians for post-treatment check-ups. Two of her four sisters died of metastatic cancer related to breast cancer, enduring bone, brain and ovarian cancer before succumbing to the disease in their early ...” View full resource at physorg.com
Most Recently Shared on October 20, 2010 at 3:12 pm By:
Detecting breast cancer recurrence http://bit.ly/9do9jO
First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2251 patients " Ann Oncol
annonc.oxfordjournals.org — “First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2251 patients " Ann Oncol” View full resource at annonc.oxfordjournals.org
Most Recently Shared on September 22, 2010 at 1:45 pm By:
JanCerny, MD, PhD Physician, Doctor, PhD, Internist, Oncologist, and Hematologist
First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast CA: safety and efficacy. http://ow.ly/2I5Ss
FDA Approves High-Dose Fulvestrant for Refractory Metastatic Breast Cancer - QualityPoint Technologies
qualitypointtech.net — “The FDA has approved a 500-mg dose of fulvestrant intramuscular injection for the treatment of HR+ metastatic breast cancer in postmenopausal women with disease progression after antiestrogen therapy.n Medscape Medical News” View full resource at qualitypointtech.net
Most Recently Shared on September 17, 2010 at 5:12 pm By:
FDA Approves High-Dose Fulvestrant for Refractory Metastatic Breast Cancer: The FDA has approved a 500-mg dose of ... http://bit.ly/bBstva
Advertisement
